Cargando…

Tribenzoatobismuth(III): a new ­polymorph

A new polymorph (β) was obtained for an active pharmaceutical ingredient, bis­muth tribenzoate, [Bi(C(6)H(5)CO(2))(3)]. The new β-polymorph is 1.05 times denser than the previously known polymorph [Rae et al. (1998 ▶). Acta Cryst. B54, 438–442]. In the β-polymorph, the Bi atom is linked with three b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tumanov, Nikolay A., Timakova, Evgenia V., Boldyreva, Elena V.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983313/
https://www.ncbi.nlm.nih.gov/pubmed/21587398
http://dx.doi.org/10.1107/S1600536810035543
Descripción
Sumario:A new polymorph (β) was obtained for an active pharmaceutical ingredient, bis­muth tribenzoate, [Bi(C(6)H(5)CO(2))(3)]. The new β-polymorph is 1.05 times denser than the previously known polymorph [Rae et al. (1998 ▶). Acta Cryst. B54, 438–442]. In the β-polymorph, the Bi atom is linked with three benzoate anions, each of them acting as a bidentate ligand, and these assemblies with C (3) point symmetry can be considered as ‘mol­ecules’. The structure of the β-polymorph has no polymeric chains, in contrast to the previously known polymorph. The ‘mol­ecules’ in the β-polymorph are stacked along [001], so that the phenyl rings of the neighbouring mol­ecules are parallel to each other. Based on the pronounced difference in the crystal structures, one can suppose that two polymorphs should differ in the dissolution kinetics and bioavailability.